The fact of the matter of the matter is that Facebook shares will almost certainly disappoint investors who participate in the IPO, because the prices being bandied about simply don’t reflect the numerous risks that are also part and parcel of the business. Here are five numbers that highlight some of those significant risks:
J.P. Morgan’s Efforts to Shield Itself From European Market Fallout Prompted Disastrous Bets
J.P. Morgan Chase & Co. told traders several months ago to make bets aimed at shielding the bank from the market fallout of Europe’s deepening mess. But instead of shrinking the risk, their complicated bets backfired into losses of as much as $200 million a day in late April and early May, people familiar with the situation said.
JPMorgan Chase, the biggest US bank, has revealed a surprise trading loss of at least $2bn (£1.2bn) on complex investments made by its traders.
Three days of arguments before the Supreme Court have made it abundantly clear – “Obamacare” is in danger of being gutted or completely wiped off the books.
Only one thing’s for sure. Investors will want to keep buying healthcare stocks -especially as 10,000 baby boomers a day turn 65 years old for the next 20 years.
But there’s one segment of the healthcare sector that will be sitting in the driver’s seat when it comes to delivering healthy profits and investment returns – no matter how the court rules.